Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Disposal

12 Mar 2010 07:00

RNS Number : 4786I
Yule Catto & Co PLC
12 March 2010
 



12 March 2010

Yule Catto & Co plc

 

Disposal of Revertex Finewaters Sdn Bhd

Yule Catto & Co plc ("the Group"), an international producer of specialty chemicals, is pleased to announce that its joint venture subsidiary, Revertex (Malaysia) Sdn Bhd, has exchanged conditional contracts with H. B. Fuller Company for the sale of Revertex Finewaters Sdn Bhd ("Revertex Finewaters").

 

The consideration to be received by the Group for its 63% effective interest in Revertex Finewaters is Malaysian Ringgit 55.6 million (£11 million) representing an 8 x multiple of EBITDA in 2009. The consideration will be paid in full in cash at completion. The proceeds of the sale will be used to reduce the Group's borrowings.

 

The completion of the sale is conditional on approval from the Malaysian regulatory authorities.

 

Revertex Finewaters is a leading Malaysian manufacturer and supplier of adhesives for industrial use in the local market and exports to other parts of South East Asia. In the twelve months to 31 December 2009 it had sales of MR 62.4 million (£13 million), an operating profit of MR 11 million (£2 million) and gross assets of MR 37.2 million (£7 million).

 

The Revertex Finewaters' management team, led by Dr Kuek Heng Thong, will continue to run the business.

 

Adrian Whitfield, Chief Executive, commented:

 

"We are pleased to have secured the sale of this non-core business to a strategic global adhesives manufacturer which allows us to focus on the development of our polymer manufacturing activities in Asia. We will continue to supply key raw materials to Revertex Finewaters from our other existing facility in Malaysia under a long term supply contract."

 

- Ends -

 

Enquiries:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Finance Director

Hogarth

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLFFVFVEILLII
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.